Association of Evaluation and Management Payment Policy Changes With Medicare Payment to Physicians by Specialty.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
28 02 2023
Historique:
entrez: 28 2 2023
pubmed: 1 3 2023
medline: 3 3 2023
Statut: ppublish

Résumé

US primary care physicians (PCPs) have lower mean incomes than specialists, likely contributing to workforce shortages. In 2021, the Centers for Medicare & Medicaid Services increased payment for evaluation and management (E/M) services and relaxed documentation requirements. These changes may have reduced the gap between primary care and specialist payment. To simulate the effect of the E/M payment policy change on total Medicare physician payments while holding volume constant and to compare these simulated changes with observed changes in total Medicare payments and E/M coding intensity, before (July-December 2020) and after (July-December 2021) the E/M payment policy change. Retrospective observational study of US office-based physicians who were in specialties with 5000 or more physicians billing Medicare and who had 50 or more fee-for-service Medicare visits before and after the E/M payment policy change. E/M payment policy changes. Outcomes included physician-level simulated volume-constant payment change, total observed Medicare payment change, and share of high-intensity (ie, level 4 or 5) E/M visits before and after the E/M payment policy change. For each specialty, the median change in each outcome was reported. The payment gap between primary care and specialty physicians was calculated as the difference between total Medicare payments to the median primary care and median specialty physician. The study population included 180 624 physicians. Repricing 2020 services yielded a simulated volume-constant payment change ranging from a 3.3% (-$4557.0) decrease for the median radiologist to an 11.0% ($3683.1) increase for the median family practice physician. After the E/M payment change, the median high-intensity share of E/M visits increased for physicians of nearly all specialties, ranging from a -4.4 percentage point increase (dermatology) to a 17.8 percentage point increase (psychiatry). The median change in total Medicare payments by specialty ranged from -4.2% (-$1782.9) for general surgery to 12.1% ($3746.9) for family practice. From July-December 2020 to July-December 2021, the payment gap between the median primary care physician and the median specialist shrank by $825.1, from $40 259.8 to $39 434.7 (primary care, $41 193.3 in July-December 2020 and $45 962.4 in July-December 2021; specialist, $81 453.1 in July-December 2020 and $85 397.1 in July-December 2021)-a relative decrease of 2.0%. Among US office-based physicians receiving Medicare payments in 2020 and 2021, E/M payment policy changes were associated with changes in Medicare payment by specialty, although the payment gap between primary care physicians and specialists decreased only modestly. The findings may have been influenced by the COVID-19 pandemic, and further research in subsequent years is needed.

Identifiants

pubmed: 36853249
pii: 2801848
doi: 10.1001/jama.2023.0879
pmc: PMC9975918
doi:

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

662-669

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

JAMA. 2018 Feb 6;319(5):441-442
pubmed: 29302693
JAMA Intern Med. 2021 Mar 1;181(3):388-391
pubmed: 33196765
Health Aff (Millwood). 2022 Jun;41(6):805-813
pubmed: 35666969
Chest. 2013 Sep;144(3):740-745
pubmed: 23764970
JAMA Intern Med. 2015 Dec;175(12):1932-9
pubmed: 26501217
Ann Intern Med. 2007 Feb 20;146(4):301-6
pubmed: 17310054
JAMA Intern Med. 2015 Jul;175(7):1229-31
pubmed: 26011666
Ann Intern Med. 2022 Apr;175(4):499-504
pubmed: 35188791
JAMA. 2020 Jul 7;324(1):96-99
pubmed: 32501493
Ann Intern Med. 2020 Apr 21;172(8):568-570
pubmed: 31931524
JAMA Intern Med. 2021 Oct 1;181(10):1412-1414
pubmed: 34228043
J Polit Econ. 2017 Feb;125(1):1-39
pubmed: 28713176
N Engl J Med. 2019 Feb 7;380(6):507-510
pubmed: 30726687
J Gen Intern Med. 2021 Mar;36(3):836-839
pubmed: 32495087
Health Aff (Millwood). 2021 Feb;40(2):349-358
pubmed: 33523745
JAMA. 2021 Oct 5;326(13):1325-1328
pubmed: 34542565

Auteurs

Hannah T Neprash (HT)

University of Minnesota, School of Public Health, Minneapolis.

Ezra Golberstein (E)

University of Minnesota, School of Public Health, Minneapolis.

Ishani Ganguli (I)

Harvard Medical School, Boston, Massachusetts.
Brigham and Women's Hospital, Boston, Massachusetts.

Michael E Chernew (ME)

Harvard Medical School, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH